Clinical Trial Update: Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating elacestrant in combination with onapristone in advanced or metastatic breast cancer has been terminated (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Elacestrant (elacestrant)
• Onapristone (onapristone)

Snippet

Sponsor: Context Therapeutics Inc. | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED